Related Articles
A multi‑targeted tyrosine kinase inhibitor lenvatinib for the treatment of mice with advanced glioblastoma
Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report
Therapeutic effects of lenvatinib in combination with rAd‑p53 for the treatment of non‑small cell lung cancer
Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis
Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report